These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36593152)

  • 21. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia.
    Fiseha T; Tamir Z
    BMC Nephrol; 2020 Apr; 21(1):129. PubMed ID: 32293323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.
    Paauw ND; van der Graaf AM; Bozoglan R; van der Ham DP; Navis G; Gansevoort RT; Groen H; Lely AT
    Am J Kidney Dis; 2018 May; 71(5):619-626. PubMed ID: 29289477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury.
    Yamamoto T; Nakayama I; Kawakatsu Y; Yamamoto T; Ishigami N; Watanuki K; Okabe T; Yokoyama H
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):887-896. PubMed ID: 31038268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
    Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
    Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community pharmacist intervention in patients with renal impairment.
    Pourrat X; Sipert AS; Gatault P; Sautenet B; Hay N; Guinard F; Guegan F; Halimi JM
    Int J Clin Pharm; 2015 Dec; 37(6):1172-9. PubMed ID: 26385098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fast GFR decline and progression to CKD among primary care patients with preserved GFR.
    Koraishy FM; Hooks-Anderson D; Salas J; Rauchman M; Scherrer JF
    Int Urol Nephrol; 2018 Mar; 50(3):501-508. PubMed ID: 29404927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
    Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
    JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis.
    Wong MG; Ninomiya T; Liyanage T; Sukkar L; Hirakawa Y; Wang Y; Wyld MLR; Morton RL; Chadban S; Howard K; Jardine MJ
    Nephrology (Carlton); 2019 Jun; 24(6):605-614. PubMed ID: 30039893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare.
    Hagnäs M; Sundqvist H; Jokelainen J; Tumminia A; Vinciguerra F; Loreto C; Frittitta L; Russo GT; Mikkola I
    Prim Care Diabetes; 2020 Dec; 14(6):639-644. PubMed ID: 32527663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.
    Gheewala PA; Zaidi STR; Jose MD; Bereznicki L; Peterson GM; Castelino RL
    J Nephrol; 2018 Feb; 31(1):27-36. PubMed ID: 28181150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Kidney Disease Diagnosis and Management: A Review.
    Chen TK; Knicely DH; Grams ME
    JAMA; 2019 Oct; 322(13):1294-1304. PubMed ID: 31573641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foot insensitivity is associated with renal function decline in patients with type 2 diabetes: a cohort study.
    Altaf QA; Sadiqi H; Piya MK; Tahrani AA
    BMC Endocr Disord; 2016 Nov; 16(1):64. PubMed ID: 27876022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.